Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
- 2017-05-30
- BMC Pediatrics 17(1)
- J. Smilowitz
- Jackelyn Moya
- Melissa A. Breck
- Chelsea Cook
- A. Fineberg
- K. Angkustsiri
- M. Underwood
- PubMed: 28558732
- DOI: 10.1186/s12887-017-0886-9
- Low evidence
- Rigorous Journal
During supplementation, watery stools decreased and soft stools increased by 36% over baseline in BiLS infants (p < 0.05) with no significant changes in stool consistency for the LS infants.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes